ATLL — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Adult T-cell leukaemia/lymphoma (ATLL) — an aggressive T-cell malignancy caused by HTLV-1
ATLL is an aggressive T-cell malignancy occurring in approximately 3–5% of HTLV-1 carriers after decades of latency. The acute form presents with lymphadenopathy, hepatosplenomegaly, skin lesions, hypercalcaemia (through osteoclast activation via PTHrP), raised LDH, and characteristic 'flower cells' (multilobulated lymphocyte nuclei). Prognosis is very poor (median survival <12 months for acute ATLL). Treatment includes combination chemotherapy ± Zidovudine/IFN-alpha (antiretroviral/immunomodulatory approach). Allogeneic HSCT may be considered in younger patients.
Reference: BHIVA 2022 – HTLV-1 guidelines; WHO 2022 – HTLV-1